BIOX logo

Bioceres Crop Solutions Corp. (BIOX) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Bioceres Crop Solutions Corp. (BIOX), Basic Materials sektöründe faaliyet gösteriyor, son olarak 0.40$'dan işlem görüyor ve 26M piyasa değerine sahip. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 42/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 8 Şub 2026
42/100 AI Puanı Hedef $2.00 (+401.4%) PD 26M Hacim 107K

Bioceres Crop Solutions Corp. (BIOX) Malzemeler ve Emtia Maruziyeti

CEOFederico Trucco
Çalışanlar400
MerkezRosario, AR
Halka Arz Yılı2018

Bioceres Crop Solutions Corp. (BIOX) is revolutionizing agriculture with its innovative HB4 drought-tolerant technology and comprehensive suite of crop productivity solutions, positioning it as a key player in sustainable farming across Argentina, Uruguay, France, South Africa, and beyond.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 8 Şub 2026

Yatırım Tezi

Bioceres Crop Solutions Corp. presents a notable research candidate due to its focus on sustainable agriculture and innovative technologies like HB4 drought-tolerant seeds. With a market capitalization of $0.04 billion, BIOX is positioned for growth as climate change necessitates more resilient crop solutions. The company's diverse product portfolio across seed, crop protection, and nutrition segments provides multiple revenue streams. While the company currently has a negative P/E ratio of -0.68 and a negative profit margin of -16.6%, the gross margin of 39.1% indicates potential for improved profitability. Key catalysts include the expansion of HB4 technology adoption and strategic partnerships to penetrate new markets. Investors may want to evaluate BIOX for its long-term growth potential in the evolving agricultural landscape.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Market Cap of $0.04B reflects the company's current valuation in the agricultural inputs market.
  • Gross Margin of 39.1% demonstrates the company's ability to generate revenue from its products and services.
  • Beta of 0.48 indicates lower volatility compared to the overall market, suggesting a relatively stable investment.
  • Operations in Argentina, Uruguay, France, and South Africa provide geographic diversification and access to different agricultural markets.
  • HB4 drought-tolerant seed technology offers a competitive advantage in regions facing water scarcity.

Rakipler & Benzerleri

Güçlü Yönler

  • Innovative HB4 drought-tolerant technology.
  • Diversified product portfolio across seed, crop protection, and nutrition.
  • Established presence in key agricultural markets.
  • Strong focus on sustainable agriculture.

Zayıflıklar

  • Negative profit margin.
  • Relatively small market capitalization.
  • Dependence on regulatory approvals for HB4 technology.
  • Exposure to currency fluctuations in Argentina.

Katalizörler

  • Upcoming: Regulatory approvals for HB4 technology in key markets.
  • Ongoing: Expansion of HB4 seed sales in existing markets.
  • Ongoing: Strategic partnerships to expand product portfolio and geographic reach.
  • Ongoing: Increased adoption of biological crop inputs.

Riskler

  • Potential: Delays in regulatory approvals for HB4 technology.
  • Potential: Competition from larger agricultural companies.
  • Ongoing: Fluctuations in commodity prices.
  • Ongoing: Adverse weather conditions impacting crop yields.
  • Potential: Currency fluctuations in Argentina affecting financial results.

Büyüme Fırsatları

  • Expansion of HB4 Technology: Bioceres has a significant growth opportunity in expanding the adoption of its HB4 drought-tolerant technology. As climate change intensifies, the demand for drought-resistant crops will increase. The market for drought-tolerant seeds is projected to grow substantially, offering Bioceres a first-mover advantage in regions facing water scarcity. Successful trials and regulatory approvals in key markets will be crucial for realizing this growth potential. This expansion can occur over the next 3-5 years.
  • Strategic Partnerships and Acquisitions: Bioceres can pursue strategic partnerships and acquisitions to expand its product portfolio and geographic reach. Collaborating with other agricultural companies or acquiring complementary businesses can provide access to new technologies, markets, and distribution channels. This strategy can accelerate growth and enhance Bioceres' competitive position in the global agricultural inputs market. The timeline for such partnerships and acquisitions is ongoing.
  • Increased Adoption of Biologicals: The growing demand for sustainable agriculture is driving the adoption of biological crop inputs, such as inoculants and bio-inductors. Bioceres is well-positioned to capitalize on this trend through its Crop Nutrition segment. Expanding the production and marketing of biological fertilizers can drive revenue growth and enhance the company's reputation as a provider of environmentally friendly solutions. This is an ongoing trend with increasing market demand.
  • Penetration of New Geographic Markets: Bioceres currently operates in Argentina, Uruguay, France, and South Africa. Expanding into new geographic markets, particularly in regions with similar agricultural conditions, can drive significant growth. Identifying and targeting key markets with unmet needs for crop productivity solutions can provide new revenue streams and diversify the company's geographic footprint. This expansion can be phased over the next 5-7 years.
  • Development of Integrated Solutions: Bioceres can further integrate its seed, crop protection, and crop nutrition offerings to provide comprehensive solutions to farmers. By bundling products and services, the company can offer greater value to customers and increase customer loyalty. This integrated approach can differentiate Bioceres from its competitors and drive revenue growth through cross-selling and upselling opportunities. This is an ongoing strategy to enhance customer value.

Fırsatlar

  • Expansion of HB4 technology adoption.
  • Strategic partnerships and acquisitions.
  • Increased adoption of biologicals.
  • Penetration of new geographic markets.

Tehditler

  • Competition from larger agricultural companies.
  • Changes in government regulations.
  • Fluctuations in commodity prices.
  • Adverse weather conditions.

Rekabet Avantajları

  • Proprietary HB4 drought-tolerant technology.
  • Integrated solutions across seed, crop protection, and nutrition.
  • Established presence in key agricultural markets.
  • Strong relationships with farmers and distributors.

BIOX Hakkında

Founded in 2001 and headquartered in Rosario, Argentina, Bioceres Crop Solutions Corp. has evolved into a prominent provider of crop productivity solutions. The company operates through three key segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment focuses on developing and commercializing cutting-edge seed technology, biotechnological events, superior germplasm, and advanced seed treatments designed to enhance crop yields and resilience. The Crop Protection segment is dedicated to producing and marketing a range of solutions, including Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits, providing farmers with the tools they need to protect their crops from pests and diseases. The Crop Nutrition segment develops, produces, and commercializes inoculants, bio-inductors, and biological and microgranulated fertilizers, promoting sustainable and efficient nutrient uptake by plants. A cornerstone of Bioceres' offerings is HB4, a proprietary drought-tolerant seed technology program that addresses the growing challenges posed by climate change. Operating in Argentina, Uruguay, France, South Africa, and other international markets, Bioceres is committed to driving agricultural innovation and sustainability on a global scale. Bioceres Crop Solutions Corp. is a subsidiary of Bioceres LLC.

Ne Yaparlar

  • Develop and commercialize seed technology and biotechnological events.
  • Produce and market crop protection products, including herbicides, insecticides, and fungicides.
  • Develop and sell crop nutrition products, such as inoculants and bio-inductors.
  • Offer HB4 drought-tolerant seed technology.
  • Provide solutions for sustainable agriculture.
  • Operate in Argentina, Uruguay, France, and South Africa.

İş Modeli

  • Sales of seed and integrated products.
  • Sales of crop protection products.
  • Sales of crop nutrition products.
  • Licensing of HB4 technology.
  • Distribution through a network of retailers and distributors.

Sektör Bağlamı

Bioceres Crop Solutions operates within the agricultural inputs industry, a sector experiencing increased demand for sustainable and efficient farming solutions. The global agricultural inputs market is projected to reach billions of dollars, driven by the need to feed a growing population while minimizing environmental impact. Key trends include the adoption of precision agriculture, the use of biologicals, and the development of climate-resilient crops. Bioceres competes with companies like ACNT, AEC, ATLX, AVD, and FSI, all vying for market share by offering innovative products and services to farmers. Bioceres' focus on HB4 technology and integrated solutions positions it as a key player in this evolving landscape.

Kilit Müşteriler

  • Farmers in Argentina, Uruguay, France, and South Africa.
  • Agricultural retailers and distributors.
  • Seed companies.
  • Food producers.
AI Güveni: 72% Güncellendi: 8 Şub 2026

Finansallar

Grafik & Bilgi

Bioceres Crop Solutions Corp. (BIOX) hisse senedi fiyatı: $0.40 (-0.02, -5.43%)

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

BIOX için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

Konsensüs hedefi: $2.00

MoonshotScore

42/100

Bu puan ne anlama geliyor?

MoonshotScore, BIOX'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

BIOX Basic Materials Hisse Senedi SSS

BIOX için değerlendirilmesi gereken temel faktörler nelerdir?

Bioceres Crop Solutions Corp. (BIOX) şu anda yapay zeka skoru 42/100, düşük puanı gösteriyor. Analist hedefi $2.00 ($0.40'dan +401%). Temel güçlü yan: Innovative HB4 drought-tolerant technology.. İzlenmesi gereken birincil risk: Potential: Delays in regulatory approvals for HB4 technology.. Bu bir finansal tavsiye değildir.

BIOX MoonshotScore'u nedir?

BIOX şu anda MoonshotScore'da 42/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

BIOX verileri ne sıklıkla güncellenir?

BIOX fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler BIOX hakkında ne diyor?

Analistler, BIOX için $2.00 konsensüs fiyat hedefi belirledi, bu mevcut fiyattan ($0.40) yukarı yönlü %401 potansiyeli temsil ediyor. Kapsam, al, tut ve sat derecelendirmelerini, kazanç tahminlerini ve son yükseltmeleri veya düşürmeleri içerir. Tüm ayrıntılar için bu sayfadaki Analist Konsensüsü bölümüne bakın.

BIOX'a yatırım yapmanın riskleri nelerdir?

BIOX için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Delays in regulatory approvals for HB4 technology.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

BIOX'ın P/E oranı nedir?

BIOX için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için BIOX'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

BIOX aşırı değerli mi, yoksa düşük değerli mi?

Bioceres Crop Solutions Corp. (BIOX)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Analist hedefi $2.00 (mevcut fiyattan +401%), analistlerin yukarı yönlü potansiyel gördüğünü gösteriyor. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

BIOX'ın temettü verimi nedir?

Bioceres Crop Solutions Corp. (BIOX) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Financial data may be subject to restatement.
  • Future performance is not guaranteed.
  • Investment decisions should be based on thorough research and consultation with a financial advisor.
Veri Kaynakları

Popüler Hisseler